




Searching News Database: MMI
Your search returned too many results! The most recent 500 items are shown below:
HSMN NewsFeed - 14 Feb 2025
AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors
AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors
HSMN NewsFeed - 6 Feb 2025
Accuryn Medical Welcomes Business Innovation Leader to Support Team in Transforming Kidney Care
Accuryn Medical Welcomes Business Innovation Leader to Support Team in Transforming Kidney Care
HSMN NewsFeed - 31 Jan 2025
U.S. FDA Approves Celltrion's AVTOZMA(R) (tocilizumab-anoh), a Biosimilar to ACTEMRA(R)
U.S. FDA Approves Celltrion's AVTOZMA(R) (tocilizumab-anoh), a Biosimilar to ACTEMRA(R)
HSMN NewsFeed - 30 Jan 2025
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
HSMN NewsFeed - 24 Jan 2025
Nuevocor Welcomes Andreas Wallnöfer as Chairman of the Board of Directors
Nuevocor Welcomes Andreas Wallnöfer as Chairman of the Board of Directors
HSMN NewsFeed - 22 Jan 2025
Shotel(TM) Medical Expansion Signals Growing Demand for Its Ankle Arthrodesis Device
Shotel(TM) Medical Expansion Signals Growing Demand for Its Ankle Arthrodesis Device
HSMN NewsFeed - 13 Jan 2025
Roche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma
Roche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma
HSMN NewsFeed - 31 Dec 2024
Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA
Kazia Therapeutics Provides Update on Paxalisib Regulatory Pathway Following Type C Meeting with FDA
HSMN NewsFeed - 23 Dec 2024
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
Traws Pharma Announces Progress in Developing Tivoxavir Marboxil for H5N1 Bird Flu
HSMN NewsFeed - 17 Dec 2024
BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations
BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations
HSMN NewsFeed - 12 Dec 2024
U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
U.S. FDA Expands Indication for Impella Heart Pumps to Treat Pediatric Patients
HSMN NewsFeed - 3 Dec 2024
Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter
Terumo Interventional Systems Announces Launch of Its R2P NaviCross Peripheral Support Catheter
HSMN NewsFeed - 26 Nov 2024
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
HSMN NewsFeed - 25 Nov 2024
LifeSignals Receives FDA 510(k) Approval for UbiqVue(TM) 2A Multiparameter System
LifeSignals Receives FDA 510(k) Approval for UbiqVue(TM) 2A Multiparameter System
HSMN NewsFeed - 22 Nov 2024
U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE(TM) Cord Blood Cell Therapy Product
U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE(TM) Cord Blood Cell Therapy Product
HSMN NewsFeed - 21 Nov 2024
SOPHiA GENETICS Launches MSK-IMPACT(R) powered with SOPHiA DDM(TM) at AMP 2024
SOPHiA GENETICS Launches MSK-IMPACT(R) powered with SOPHiA DDM(TM) at AMP 2024
HSMN NewsFeed - 18 Nov 2024
Zimmer Biomet Announces CE Mark Certification for Persona(R) Revision Knee System
Zimmer Biomet Announces CE Mark Certification for Persona(R) Revision Knee System
HSMN NewsFeed - 24 Oct 2024
Pillar Biosciences Receives CPT(R) Code for FDA Approved oncoReveal(TM) CDx Pan-Cancer Solid tumor IVD Kit
Pillar Biosciences Receives CPT(R) Code for FDA Approved oncoReveal(TM) CDx Pan-Cancer Solid tumor IVD Kit
HSMN NewsFeed - 17 Oct 2024
MolecuLight's Fluorescence Imaging: A Game-Changer for Bedside Biofilm Detection
MolecuLight's Fluorescence Imaging: A Game-Changer for Bedside Biofilm Detection
HSMN NewsFeed - 15 Oct 2024
Accure Acne Announces New FDA Clearance for the Long-Term Treatment of Acne
Accure Acne Announces New FDA Clearance for the Long-Term Treatment of Acne
HSMN NewsFeed - 9 Oct 2024
Inspira(TM) Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism
Inspira(TM) Announces Development of New Disposable Kit with Built-In Performance Monitoring Mechanism
HSMN NewsFeed - 2 Oct 2024
Kedrion and Biotest complete long-term Exclusive Distribution Agreement for Yimmugo(R) in the US
Kedrion and Biotest complete long-term Exclusive Distribution Agreement for Yimmugo(R) in the US
HSMN NewsFeed - 27 Sep 2024
Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE(TM) Pulsed Field Ablation System
Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE(TM) Pulsed Field Ablation System
HSMN NewsFeed - 19 Sep 2024
FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis
FDA Declines to Approve Vanda's Marketing Application for Tradipitant in Gastroparesis
HSMN NewsFeed - 10 Sep 2024
Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.(R) Therapy
Solventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.(R) Therapy
HSMN NewsFeed - 9 Sep 2024
Lilly appoints Lucas Montarce as executive vice president and chief financial officer
Lilly appoints Lucas Montarce as executive vice president and chief financial officer
HSMN NewsFeed - 5 Sep 2024
Pfizer Appoints Elif Aral as Regional President for the Middle East, Russia & Africa
Pfizer Appoints Elif Aral as Regional President for the Middle East, Russia & Africa
HSMN NewsFeed - 4 Sep 2024
Vesalio launches pVasc Thrombectomy System in the U.S. for peripheral occlusions
Vesalio launches pVasc Thrombectomy System in the U.S. for peripheral occlusions
HSMN NewsFeed - 3 Sep 2024
Iridium Network becomes first center in the world to use RayCare and TrueBeam to treat a patient
Iridium Network becomes first center in the world to use RayCare and TrueBeam to treat a patient
HSMN NewsFeed - 29 Aug 2024
Expanse Medical Welcomes Jeff Hopkins as CEO and Board Member of its Spin-Off, FlowPhysix
Expanse Medical Welcomes Jeff Hopkins as CEO and Board Member of its Spin-Off, FlowPhysix
HSMN NewsFeed - 28 Aug 2024
Neuros Medical Receives FDA Approval for the Altius(R) Direct Electrical Nerve Stimulation System
Neuros Medical Receives FDA Approval for the Altius(R) Direct Electrical Nerve Stimulation System
HSMN NewsFeed - 26 Aug 2024
Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation
Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation
HSMN NewsFeed - 22 Aug 2024
Stratus Medical Announces Exclusive Distribution Agreement with Edge Medical for the United Kingdom
Stratus Medical Announces Exclusive Distribution Agreement with Edge Medical for the United Kingdom
HSMN NewsFeed - 19 Aug 2024
Visiox Pharmaceuticals, Inc. Announces Transformative Merger with Ocuvex Therpeutics, Inc.
Visiox Pharmaceuticals, Inc. Announces Transformative Merger with Ocuvex Therpeutics, Inc.
HSMN NewsFeed - 15 Aug 2024
Haemonetics Announces Full Market Release for VASCADE MVP(R) XL Vascular Closure System
Haemonetics Announces Full Market Release for VASCADE MVP(R) XL Vascular Closure System
HSMN NewsFeed - 5 Aug 2024
Mallinckrodt Reaches Agreement to Sell Therakos(R) Business to CVC for $925 Million
Mallinckrodt Reaches Agreement to Sell Therakos(R) Business to CVC for $925 Million
HSMN NewsFeed - 1 Aug 2024
Jade Biosciences Launches with $80 Million to Develop Transformative Therapies for Autoimmune Diseases
Jade Biosciences Launches with $80 Million to Develop Transformative Therapies for Autoimmune Diseases
HSMN NewsFeed - 25 Jul 2024
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases
HSMN NewsFeed - 24 Jul 2024
Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment
Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment
HSMN NewsFeed - 22 Jul 2024
Latigo Biotherapeutics Appoints Nima Farzan as Chief Executive Officer, Positioning Company for Rapid Growth
Latigo Biotherapeutics Appoints Nima Farzan as Chief Executive Officer, Positioning Company for Rapid Growth
HSMN NewsFeed - 12 Jul 2024
Bedal International raises $11 Million to boost growth of its FlexGRIP(R) catheter securement devices
Bedal International raises $11 Million to boost growth of its FlexGRIP(R) catheter securement devices
HSMN NewsFeed - 8 Jul 2024
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
HSMN NewsFeed - 26 Jun 2024
BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn(R) Clinical Trial
BrainStorm Cell Therapeutics Reaches Alignment with FDA on CMC Aspects of Phase 3b NurOwn(R) Clinical Trial
HSMN NewsFeed - 19 Jun 2024
European Commission grants Sobi(R) Marketing Authorisation for ALTUVOCT(TM) for treatment of haemophilia A
European Commission grants Sobi(R) Marketing Authorisation for ALTUVOCT(TM) for treatment of haemophilia A
HSMN NewsFeed - 18 Jun 2024
Roche receives FDA clearance on its digital pathology solution for diagnostic use
Roche receives FDA clearance on its digital pathology solution for diagnostic use
HSMN NewsFeed - 17 Jun 2024
Raya Therapeutic Announces Supportive Clinical Results of Fasudil (RT1968) in ALS Patients
Raya Therapeutic Announces Supportive Clinical Results of Fasudil (RT1968) in ALS Patients
HSMN NewsFeed - 11 Jun 2024
Amber Implants Completes Enrollment of First-In-Human Clinical Trial of its VCFix(R) Spinal System
Amber Implants Completes Enrollment of First-In-Human Clinical Trial of its VCFix(R) Spinal System
HSMN NewsFeed - 31 May 2024
SIFI Receives Positive CHMP Opinion for Akantior(R) (polihexanide 0.08%) in Acanthamoeba Keratitis
SIFI Receives Positive CHMP Opinion for Akantior(R) (polihexanide 0.08%) in Acanthamoeba Keratitis
HSMN NewsFeed - 28 May 2024
Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView(TM) Monitoring System
Terumo Cardiovascular Announces 510(K) Clearance for the CDI OneView(TM) Monitoring System
HSMN NewsFeed - 22 May 2024
Virtual-Ports Receives CE Certification for Revolutionary Surgical Products
Virtual-Ports Receives CE Certification for Revolutionary Surgical Products
HSMN NewsFeed - 6 May 2024
Scientia Vascular Announces FDA approvals for New Line of Microfabricated Neurovascular Catheters
Scientia Vascular Announces FDA approvals for New Line of Microfabricated Neurovascular Catheters
HSMN NewsFeed - 3 Apr 2024
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
Kintara Therapeutics and TuHURA Biosciences Enter into Definitive Merger Agreement
HSMN NewsFeed - 25 Mar 2024
Sirtex Medical Appoints Matt Schmidt as New Chief Executive Officer and Board of Directors Member
Sirtex Medical Appoints Matt Schmidt as New Chief Executive Officer and Board of Directors Member
HSMN NewsFeed - 18 Mar 2024
Syndax Announces Appointment of Steven Closter as Chief Commercial Officer
Syndax Announces Appointment of Steven Closter as Chief Commercial Officer
HSMN NewsFeed - 7 Mar 2024
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
BioMarin Announces Appointment of Cristin Hubbard as Chief Commercial Officer
HSMN NewsFeed - 1 Mar 2024
Boston Scientific Receives FDA Approval for the AGENT(TM) Drug-Coated Balloon
Boston Scientific Receives FDA Approval for the AGENT(TM) Drug-Coated Balloon
HSMN NewsFeed - 29 Feb 2024
Spatz Medical Marks Milestone: Spatz3 Adjustable Gastric Balloon Launches in the U.S. in March 2024
Spatz Medical Marks Milestone: Spatz3 Adjustable Gastric Balloon Launches in the U.S. in March 2024
HSMN NewsFeed - 29 Feb 2024
Spineart Completes Enrollment in the BAGUERA(R)C IDE Trial for Single-Level Cervical Disc Replacement
Spineart Completes Enrollment in the BAGUERA(R)C IDE Trial for Single-Level Cervical Disc Replacement
HSMN NewsFeed - 21 Feb 2024
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
AbbVie Announces Appointment of Robert A. Michael as Chief Executive Officer
HSMN NewsFeed - 15 Feb 2024
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
Freenome Raises $254 Million in New Funding to Accelerate its Platform for Early Cancer Detection
HSMN NewsFeed - 14 Feb 2024
Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead
Dr. Lisa Johnson-Pratt Joins Aspen Neuroscience as Senior Vice President, Therapeutic Program Lead
HSMN NewsFeed - 14 Feb 2024
Latigo Biotherapeutics Debuts with $135 Million Series A Financing to Develop Non-Opioid Pain Medicines
Latigo Biotherapeutics Debuts with $135 Million Series A Financing to Develop Non-Opioid Pain Medicines
HSMN NewsFeed - 7 Feb 2024
Innova Vascular Announces Successful Early Commercial Use of Laguna Thrombectomy System(TM) in Patients
Innova Vascular Announces Successful Early Commercial Use of Laguna Thrombectomy System(TM) in Patients
HSMN NewsFeed - 6 Feb 2024
FDA Clears Groundbreaking Corplex P(TM): The First Human Umbilical Cord-Derived Medical Device
FDA Clears Groundbreaking Corplex P(TM): The First Human Umbilical Cord-Derived Medical Device
HSMN NewsFeed - 31 Jan 2024
Labcorp Launches New Test for Risk Assessment and Prognosis of Severe Preeclampsia in Pregnant Women
Labcorp Launches New Test for Risk Assessment and Prognosis of Severe Preeclampsia in Pregnant Women
HSMN NewsFeed - 23 Jan 2024
FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer
FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer
HSMN NewsFeed - 22 Jan 2024
CalciMedica Announces Private Placement of up to Approximately $55 Million
CalciMedica Announces Private Placement of up to Approximately $55 Million
HSMN NewsFeed - 18 Jan 2024
Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert(R) Xpress MVP
Cepheid Receives Expanded FDA Clearance with CLIA Waiver for Xpert(R) Xpress MVP
HSMN NewsFeed - 4 Jan 2024
Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect(TM)
Lilly Launches End-to-End Digital Healthcare Experience through LillyDirect(TM)
HSMN NewsFeed - 18 Dec 2023
NeuExcell's AAV Gene Therapy for Malignant Glioma Granted Orphan Drug Designation by FDA
NeuExcell's AAV Gene Therapy for Malignant Glioma Granted Orphan Drug Designation by FDA
HSMN NewsFeed - 15 Dec 2023
CymaBay Submits New Drug Application to FDA for Seladelpar for the Treatment of Primary Biliary Cholangitis
CymaBay Submits New Drug Application to FDA for Seladelpar for the Treatment of Primary Biliary Cholangitis
HSMN NewsFeed - 13 Dec 2023
Triveni Bio Welcomes Jeff Albers and Allison Luo to its Board of Directors
Triveni Bio Welcomes Jeff Albers and Allison Luo to its Board of Directors
HSMN NewsFeed - 11 Dec 2023
Hummingbird Bioscience Strengthens Leadership Team with Appointment of Angèle Maki as Chief Business Officer
Hummingbird Bioscience Strengthens Leadership Team with Appointment of Angèle Maki as Chief Business Officer
HSMN NewsFeed - 7 Dec 2023
BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
BD Receives FDA 510(k) Clearance for Potentially Transformative Fingertip Blood Collection Device
HSMN NewsFeed - 6 Dec 2023
NSite Medical Announces FDA Clearance for Groundbreaking AI-Based Scoliosis Scanning App
NSite Medical Announces FDA Clearance for Groundbreaking AI-Based Scoliosis Scanning App
HSMN NewsFeed - 30 Nov 2023
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency
BD Launches Advanced Vascular Access Ultrasound System Designed to Improve Clinician Efficiency
HSMN NewsFeed - 29 Nov 2023
Biolexis Secures $10 Million in Series A Funding to Advance Metabolic Drug Development
Biolexis Secures $10 Million in Series A Funding to Advance Metabolic Drug Development
HSMN NewsFeed - 17 Nov 2023
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
Novavax Makes Changes to Executive Leadership Team to Enhance Focus on Delivery of Strategic Priorities
HSMN NewsFeed - 10 Nov 2023
EU Approval of AAV5 DetectCDx(TM) Provides Access to Companion Diagnostic for Hemophilia A Gene Therapy
EU Approval of AAV5 DetectCDx(TM) Provides Access to Companion Diagnostic for Hemophilia A Gene Therapy
HSMN NewsFeed - 7 Nov 2023
Johnson & Johnson MedTech Provides Details and Timeline for General Surgery Robot
Johnson & Johnson MedTech Provides Details and Timeline for General Surgery Robot
HSMN NewsFeed - 6 Nov 2023
NeuroBo Pharmaceuticals Strengthens Board of Directors with the Appointment of James P. Tursi, M.D.
NeuroBo Pharmaceuticals Strengthens Board of Directors with the Appointment of James P. Tursi, M.D.
HSMN NewsFeed - 24 Oct 2023
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn(R) for the Treatment of ALS
BrainStorm Cell Therapeutics Announces Strategic Realignment Prioritizing NurOwn(R) for the Treatment of ALS
HSMN NewsFeed - 16 Oct 2023
Cordis issues statement on the CMS announcement to expand coverage of carotid stenting
Cordis issues statement on the CMS announcement to expand coverage of carotid stenting
HSMN NewsFeed - 5 Oct 2023
AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline
AbbVie Exercises Exclusive Right to Acquire Mitokinin, Further Strengthening Neuroscience Pipeline
HSMN NewsFeed - 3 Oct 2023
Amber Implants Announces Start of Clinical Trial with VCFix(R) Spinal System
Amber Implants Announces Start of Clinical Trial with VCFix(R) Spinal System
HSMN NewsFeed - 26 Sep 2023
Gensco(R) Pharma Announces RizaFilm(R) Commercialization Update in the United States
Gensco(R) Pharma Announces RizaFilm(R) Commercialization Update in the United States
HSMN NewsFeed - 21 Sep 2023
Medtronic Diabetes announces CE Mark for new Simplera(TM) CGM with disposable all-in-one design
Medtronic Diabetes announces CE Mark for new Simplera(TM) CGM with disposable all-in-one design
HSMN NewsFeed - 20 Sep 2023
IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer
IceCure Medical Receives FDA Response to De Novo Classification Request for Breast Cancer
HSMN NewsFeed - 19 Sep 2023
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
Boston Scientific Announces Agreement to Acquire Relievant Medsystems, Inc.
HSMN NewsFeed - 18 Sep 2023
MiRus(R) Announces Launch of Molybdenum-Rhenium Low Profile ATLAS(TM) MoRe(R) Foot and Ankle Plating System
MiRus(R) Announces Launch of Molybdenum-Rhenium Low Profile ATLAS(TM) MoRe(R) Foot and Ankle Plating System
HSMN NewsFeed - 12 Sep 2023
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors
Protalix BioTherapeutics Appoints Eliot Richard Forster, Ph.D. as Chairman of its Board of Directors
HSMN NewsFeed - 7 Sep 2023
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer
HSMN NewsFeed - 6 Sep 2023
OncoResponse Announces Appointment of Carol Gallagher to Board of Directors
OncoResponse Announces Appointment of Carol Gallagher to Board of Directors
HSMN NewsFeed - 30 Aug 2023
Alkermes Announces Settlement With Teva Related to VIVITROL(R) Patent Litigation
Alkermes Announces Settlement With Teva Related to VIVITROL(R) Patent Litigation
HSMN NewsFeed - 29 Aug 2023
Haemonetics Announces European Expansion for VASCADE(R) Vascular Closure System
Haemonetics Announces European Expansion for VASCADE(R) Vascular Closure System
HSMN NewsFeed - 23 Aug 2023
Fresenius Medical Care Announces FDA Clearance of Versi(R)HD with GuideMe Software
Fresenius Medical Care Announces FDA Clearance of Versi(R)HD with GuideMe Software
HSMN NewsFeed - 21 Aug 2023
magAssist's NyokAssist(TM) granted Designation by the FDA as a Breakthrough Device
magAssist's NyokAssist(TM) granted Designation by the FDA as a Breakthrough Device
HSMN NewsFeed - 18 Aug 2023
FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy
FDA grants priority review for full approval of TARPEYO for the treatment of IgA Nephropathy
HSMN NewsFeed - 15 Aug 2023
Vertos Medical Promotes Two Senior Leaders to Newly Created C-Suite Roles
Vertos Medical Promotes Two Senior Leaders to Newly Created C-Suite Roles
HSMN NewsFeed - 7 Aug 2023
Ligandal Inc. Appoints Tushar Nuwal as Chief Operating Officer and Chief Business Officer
Ligandal Inc. Appoints Tushar Nuwal as Chief Operating Officer and Chief Business Officer
HSMN NewsFeed - 1 Aug 2023
BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
BD Receives 510(k) Clearance for COVID-19, Influenza A/B, RSV Molecular Combination Test
HSMN NewsFeed - 24 Jul 2023
BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD Alaris(TM) Infusion System
BD CEO Tom Polen Addresses FDA 510(k) Clearance of BD Alaris(TM) Infusion System
HSMN NewsFeed - 21 Jul 2023
Hubly Surgical Raises $3 Million in Oversubscribed Funding Round Following FDA Clearance
Hubly Surgical Raises $3 Million in Oversubscribed Funding Round Following FDA Clearance
HSMN NewsFeed - 11 Jul 2023
GI Dynamics Announces Company Rebrand as Morphic Medical(R) Reintroducing Flagship Product as RESET(R)
GI Dynamics Announces Company Rebrand as Morphic Medical(R) Reintroducing Flagship Product as RESET(R)
HSMN NewsFeed - 23 Jun 2023
Regulus Therapeutics Announces Appointment of Preston S. Klassen, M.D. to its Board of Directors
Regulus Therapeutics Announces Appointment of Preston S. Klassen, M.D. to its Board of Directors
HSMN NewsFeed - 21 Jun 2023
Aethlon Medical Announces Investigation of the Hemopurifier(R) for Use in Organ Transplantation
Aethlon Medical Announces Investigation of the Hemopurifier(R) for Use in Organ Transplantation
HSMN NewsFeed - 15 Jun 2023
Revolutionizing Cranial Neurosurgery: Novarad's VisAR Augmented Reality System Shatters Surgical Boundaries
Revolutionizing Cranial Neurosurgery: Novarad's VisAR Augmented Reality System Shatters Surgical Boundaries
HSMN NewsFeed - 13 Jun 2023
VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian(R) MRI-Guided Radiation Therapy System
VA Oklahoma City Healthcare System Chooses ViewRay's MRIdian(R) MRI-Guided Radiation Therapy System
HSMN NewsFeed - 8 Jun 2023
Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430
Astellas and Kate Therapeutics Announce Exclusive License Agreement for KT430
HSMN NewsFeed - 24 May 2023
Artelon, Inc. Secures $20M in Funding to Advance Surgical Treatment of Joint Instability
Artelon, Inc. Secures $20M in Funding to Advance Surgical Treatment of Joint Instability
HSMN NewsFeed - 16 May 2023
BD Gains 510(k) Clearance of Artificial Intelligence Software for MRSA Diagnostics
BD Gains 510(k) Clearance of Artificial Intelligence Software for MRSA Diagnostics
HSMN NewsFeed - 16 May 2023
Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry
Flagship Pioneering Launches Metaphore Biotechnologies to Unlock the Therapeutic Potential of Biomimicry
HSMN NewsFeed - 15 May 2023
Potrero Medical Announces Maclean Health as Government Sector Distributor of Record
Potrero Medical Announces Maclean Health as Government Sector Distributor of Record
HSMN NewsFeed - 18 Apr 2023
Neuspera Medical(R) Announces FDA Clearance of its System for Peripheral Nerve Stimulation
Neuspera Medical(R) Announces FDA Clearance of its System for Peripheral Nerve Stimulation
HSMN NewsFeed - 6 Apr 2023
Icentia Receives U.S. Food and Drug Administration (FDA) Clearance for CardioSTAT(R)
Icentia Receives U.S. Food and Drug Administration (FDA) Clearance for CardioSTAT(R)
HSMN NewsFeed - 30 Mar 2023
FDA approves Bioretec's RemeOs(TM) trauma screw as the first bioresorbable metal implant in the U.S. market
FDA approves Bioretec's RemeOs(TM) trauma screw as the first bioresorbable metal implant in the U.S. market
HSMN NewsFeed - 28 Feb 2023
Verismo Therapeutics Announces $7 Million Pre-Series A with BRV Capital Management as Lead Investor
Verismo Therapeutics Announces $7 Million Pre-Series A with BRV Capital Management as Lead Investor
HSMN NewsFeed - 27 Feb 2023
Viatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023
Viatris Announces Appointment of Scott A. Smith as CEO Effective April 1, 2023
HSMN NewsFeed - 17 Feb 2023
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
Medtronic Receives CE Mark for Extravascular Defibrillator System That Treats Abnormal Heart Rhythms
HSMN NewsFeed - 16 Feb 2023
Zephyrus Innovations announces US FDA approval for its Aeroject(TM) 3ml safety syringe
Zephyrus Innovations announces US FDA approval for its Aeroject(TM) 3ml safety syringe
HSMN NewsFeed - 15 Feb 2023
Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL
Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL
HSMN NewsFeed - 2 Feb 2023
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
Tezspire(R) Approved for Self-Administration in the U.S. with a New Pre-Filled Pen
HSMN NewsFeed - 27 Jan 2023
Infinity Neuro Receives CE Mark Approval for Their First Device to Treat Stroke
Infinity Neuro Receives CE Mark Approval for Their First Device to Treat Stroke
HSMN NewsFeed - 26 Jan 2023
FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy
FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy
HSMN NewsFeed - 26 Jan 2023
Cardinal Health Teams Up with Palantir to Deliver a Clinically Integrated Supply Chain Solution
Cardinal Health Teams Up with Palantir to Deliver a Clinically Integrated Supply Chain Solution
HSMN NewsFeed - 18 Jan 2023
NeuroBo Pharmaceuticals Appoints Joseph Hooker as Interim Chief Executive Officer and President
NeuroBo Pharmaceuticals Appoints Joseph Hooker as Interim Chief Executive Officer and President
HSMN NewsFeed - 16 Jan 2023
PENTAX Medical to launch new premium video processor and endoscope series
PENTAX Medical to launch new premium video processor and endoscope series
HSMN NewsFeed - 12 Jan 2023
Mallinckrodt Announces Appointment of Dr. Peter Richardson, MRCP, as Chief Scientific Officer
Mallinckrodt Announces Appointment of Dr. Peter Richardson, MRCP, as Chief Scientific Officer
HSMN NewsFeed - 9 Jan 2023
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
Boehringer Ingelheim and 3T Biosciences Join Forces to Develop Next-Generation Cancer Immunotherapies
HSMN NewsFeed - 6 Jan 2023
Aeglea BioTherapeutics Announces Update to Corporate Structure to Increase Operational Efficiency
Aeglea BioTherapeutics Announces Update to Corporate Structure to Increase Operational Efficiency
HSMN NewsFeed - 28 Dec 2022
Inspira(TM) Technologies Signs Strategic OEM Agreement with Terumo Cardiovascular
Inspira(TM) Technologies Signs Strategic OEM Agreement with Terumo Cardiovascular
HSMN NewsFeed - 27 Dec 2022
BrainStorm Cell Therapeutics Announces Type A Meeting with FDA Granted for NurOwn(R)
BrainStorm Cell Therapeutics Announces Type A Meeting with FDA Granted for NurOwn(R)
HSMN NewsFeed - 21 Dec 2022
Biomica Raises $20 Million in a Financing Round to Advance its Pipeline of Microbiome-based Therapeutics
Biomica Raises $20 Million in a Financing Round to Advance its Pipeline of Microbiome-based Therapeutics
HSMN NewsFeed - 12 Dec 2022
Amgen to Host Webcast Investor Call Following Announced Acquisition of Horizon Therapeutics
Amgen to Host Webcast Investor Call Following Announced Acquisition of Horizon Therapeutics
HSMN NewsFeed - 12 Dec 2022
IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit
IRRAS Receives US FDA 510(k) Clearance for its Next Generation IRRAflow Control Unit
HSMN NewsFeed - 30 Nov 2022
Aeglea BioTherapeutics Appoints Jeffrey M. Goldberg as Chief Executive Officer
Aeglea BioTherapeutics Appoints Jeffrey M. Goldberg as Chief Executive Officer
HSMN NewsFeed - 29 Nov 2022
Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
Boston Scientific Announces Agreement to Acquire Apollo Endosurgery, Inc.
HSMN NewsFeed - 22 Nov 2022
FDA Clears the Accure Laser System for the Treatment of Mild to Severe Inflammatory Acne Vulgaris
FDA Clears the Accure Laser System for the Treatment of Mild to Severe Inflammatory Acne Vulgaris
HSMN NewsFeed - 18 Nov 2022
Synaptogenix Announces $15 Million Private Placement with Existing Investors
Synaptogenix Announces $15 Million Private Placement with Existing Investors
HSMN NewsFeed - 17 Nov 2022
Upstaza(TM) Gene Therapy Granted Marketing Authorization for AADC deficiency by UK's MHRA
Upstaza(TM) Gene Therapy Granted Marketing Authorization for AADC deficiency by UK's MHRA
HSMN NewsFeed - 11 Nov 2022
New Company UmiTEQ Aims to Revolutionize Ultra Minimally Invasive Procedures
New Company UmiTEQ Aims to Revolutionize Ultra Minimally Invasive Procedures
HSMN NewsFeed - 8 Nov 2022
IceCure's ProSense(R) Achieves Significant Milestone in Medicare Coverage of Breast Cancer Procedures
IceCure's ProSense(R) Achieves Significant Milestone in Medicare Coverage of Breast Cancer Procedures
HSMN NewsFeed - 21 Oct 2022
Regeneron Receives Six Months of U.S. Pediatric Exclusivity for EYLEA(R) (aflibercept) Injection
Regeneron Receives Six Months of U.S. Pediatric Exclusivity for EYLEA(R) (aflibercept) Injection
HSMN NewsFeed - 17 Oct 2022
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
Medtronic First to Receive FDA Approval for Pacing the Heart's Natural Conduction System
HSMN NewsFeed - 14 Oct 2022
Dr. George W. Sledge, Jr. Joins Caris Life Sciences as Chief Medical Officer
Dr. George W. Sledge, Jr. Joins Caris Life Sciences as Chief Medical Officer
HSMN NewsFeed - 6 Oct 2022
Award-Winning SkinPen(R) Precision Announces New and Expanded Approved Indications
Award-Winning SkinPen(R) Precision Announces New and Expanded Approved Indications
HSMN NewsFeed - 27 Sep 2022
B. Braun Acquires Clik-FIX(R) Catheter Securement Devices from Starboard Medical
B. Braun Acquires Clik-FIX(R) Catheter Securement Devices from Starboard Medical
HSMN NewsFeed - 20 Sep 2022
Zimmer Biomet Receives FDA Clearance for Identity(TM) Shoulder System for Shoulder Replacement
Zimmer Biomet Receives FDA Clearance for Identity(TM) Shoulder System for Shoulder Replacement
HSMN NewsFeed - 20 Sep 2022
MD Anderson Cancer Center Selects ViewRay to Expand MR-Guided Radiation Therapy Program
MD Anderson Cancer Center Selects ViewRay to Expand MR-Guided Radiation Therapy Program
HSMN NewsFeed - 19 Sep 2022
Mallinckrodt Announces Appointment of Lisa French as Chief Commercial Officer
Mallinckrodt Announces Appointment of Lisa French as Chief Commercial Officer
HSMN NewsFeed - 14 Sep 2022
Dr. Seth Blacksburg Joins Accuray as VP, Chief Medical Officer Americas Region
Dr. Seth Blacksburg Joins Accuray as VP, Chief Medical Officer Americas Region
HSMN NewsFeed - 13 Sep 2022
BD Launches Next Generation Prefillable Vaccine Syringe Designed for Reliability, Efficiency
BD Launches Next Generation Prefillable Vaccine Syringe Designed for Reliability, Efficiency
HSMN NewsFeed - 12 Sep 2022
Haemonetics Earns CE Mark for VASCADE(R) Vascular Closure Product Portfolio
Haemonetics Earns CE Mark for VASCADE(R) Vascular Closure Product Portfolio
HSMN NewsFeed - 7 Sep 2022
ViewRay Announces China NMPA Approval of its MRIdian(R) MRI-Guided Radiation Therapy for Cancer Patients
ViewRay Announces China NMPA Approval of its MRIdian(R) MRI-Guided Radiation Therapy for Cancer Patients
HSMN NewsFeed - 1 Sep 2022
Nevro Announces Multiple Positive Coverage Updates for the Treatment of Painful Diabetic Neuropathy
Nevro Announces Multiple Positive Coverage Updates for the Treatment of Painful Diabetic Neuropathy
HSMN NewsFeed - 31 Aug 2022
iQure Pharma Secures $600K in Early Closing to Research Neuropathic Pain Therapies
iQure Pharma Secures $600K in Early Closing to Research Neuropathic Pain Therapies
HSMN NewsFeed - 24 Aug 2022
Aeglea BioTherapeutics Announces Leadership Transition and Corporate Restructuring
Aeglea BioTherapeutics Announces Leadership Transition and Corporate Restructuring
HSMN NewsFeed - 24 Aug 2022
Biotheryx Announces Appointment of Tracy Lawhon as Chief Development Officer
Biotheryx Announces Appointment of Tracy Lawhon as Chief Development Officer
HSMN NewsFeed - 23 Aug 2022
VA Houston Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
VA Houston Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
HSMN NewsFeed - 23 Aug 2022
IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study
IRRAS Announces First Patient Treatments at Mount Sinai Health System in New York as Part of the DIVE Study
HSMN NewsFeed - 22 Aug 2022
Biosion, Inc. Appoints Steven Knapp, Pharm.D. as Chief Regulatory & Quality Officer
Biosion, Inc. Appoints Steven Knapp, Pharm.D. as Chief Regulatory & Quality Officer
HSMN NewsFeed - 9 Aug 2022
ImmPACT Bio Names Vikram Lamba as Chief Financial Officer and Head of Business Development
ImmPACT Bio Names Vikram Lamba as Chief Financial Officer and Head of Business Development
HSMN NewsFeed - 1 Aug 2022
Armata Pharmaceuticals Announces Clearance of IND for Prosthetic Joint Infections
Armata Pharmaceuticals Announces Clearance of IND for Prosthetic Joint Infections
HSMN NewsFeed - 29 Jul 2022
Novasenta Completes $40 million Series A to Advance Novel Cancer Therapeutics
Novasenta Completes $40 million Series A to Advance Novel Cancer Therapeutics
HSMN NewsFeed - 27 Jul 2022
Eisai Announces Key Executive Appointment for Alzheimer's Disease Leadership
Eisai Announces Key Executive Appointment for Alzheimer's Disease Leadership
HSMN NewsFeed - 20 Jul 2022
AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma
AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma
HSMN NewsFeed - 19 Jul 2022
Gracell Biotechnologies Appoints Veteran BioPharma Executive Dr. Samuel Zhang as Chief Business Officer
Gracell Biotechnologies Appoints Veteran BioPharma Executive Dr. Samuel Zhang as Chief Business Officer
HSMN NewsFeed - 13 Jul 2022
Immunitas Therapeutics Appoints Lynette Herscha as Chief Operating Officer
Immunitas Therapeutics Appoints Lynette Herscha as Chief Operating Officer
HSMN NewsFeed - 12 Jul 2022
Smith & Nephew launches Clinical Support App to help reduce practice variation in wound care
Smith & Nephew launches Clinical Support App to help reduce practice variation in wound care
HSMN NewsFeed - 7 Jul 2022
Kernal Biologics Announces $25M Series A Financing to Advance its mRNA 2.0 Technology for Oncology
Kernal Biologics Announces $25M Series A Financing to Advance its mRNA 2.0 Technology for Oncology
HSMN NewsFeed - 6 Jul 2022
Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén
Immunic, Inc. Strengthens Its Board of Directors with the Appointment of Maria Törnsén
HSMN NewsFeed - 30 Jun 2022
BD Launches Combination Test for COVID-19, Influenza A/B and Respiratory Syncytial Virus
BD Launches Combination Test for COVID-19, Influenza A/B and Respiratory Syncytial Virus
HSMN NewsFeed - 29 Jun 2022
Artax Biopharma Appoints D. Scott Batty, Jr., M.D. as Chief Medical Officer
Artax Biopharma Appoints D. Scott Batty, Jr., M.D. as Chief Medical Officer
HSMN NewsFeed - 28 Jun 2022
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
HSMN NewsFeed - 21 Jun 2022
Chemomab Therapeutics Appoints Jill M. Quigley, JD, to Its Board of Directors
Chemomab Therapeutics Appoints Jill M. Quigley, JD, to Its Board of Directors
HSMN NewsFeed - 15 Jun 2022
RADICAVA ORS(R) (edaravone) Now Available in the U.S. for the Treatment of ALS
RADICAVA ORS(R) (edaravone) Now Available in the U.S. for the Treatment of ALS
HSMN NewsFeed - 13 Jun 2022
STRM.BIO Appoints Vanessa Salazar as Vice President of Business Development
STRM.BIO Appoints Vanessa Salazar as Vice President of Business Development
HSMN NewsFeed - 9 Jun 2022
VA Ann Arbor Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
VA Ann Arbor Healthcare System Selects ViewRay to Expand Advanced Radiation Therapy Services
HSMN NewsFeed - 6 Jun 2022
Ethicon Launches Next Generation Echelon(TM) 3000 Stapler Designed for Exceptional Access and Control
Ethicon Launches Next Generation Echelon(TM) 3000 Stapler Designed for Exceptional Access and Control
HSMN NewsFeed - 2 Jun 2022
Henry Ford Health Becomes the First Center to Treat Patients with ViewRay's MRIdian A3i System
Henry Ford Health Becomes the First Center to Treat Patients with ViewRay's MRIdian A3i System
HSMN NewsFeed - 27 May 2022
Accord Healthcare Adds Pemetrexed Lyo. Injection to Generic Drug Portfolio
Accord Healthcare Adds Pemetrexed Lyo. Injection to Generic Drug Portfolio
HSMN NewsFeed - 20 May 2022
PTC Therapeutics Receives Positive CHMP Opinion for Upstaza(TM) for the Treatment of AADC Deficiency
PTC Therapeutics Receives Positive CHMP Opinion for Upstaza(TM) for the Treatment of AADC Deficiency
HSMN NewsFeed - 17 May 2022
Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics Entrepreneur
Vyriad, Inc. Raises $29.5M in Series B Funding Led by Renowned Genetics Entrepreneur
Additional items found! 500

Members Archive contains
500 additional stories matching:
MMI
(Password required)
MMI
(Password required)